Royal London Asset Management LTD Sarepta Therapeutics, Inc. Transaction History

Royal London Asset Management LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 02, 2021	SELL	$65.97 - $92.48 $1.87 Million - $2.62 Million	-28,298 Closed	0 $0
Q2 2021 Oct 18, 2022	BUY	$69.38 - $86.75 $1.96 Million - $2.45 Million	28,298 New	28,298 $2.2 Million
Q1 2021 Apr 13, 2021	BUY	$72.25 - $168.95 $112,782 - $263,730	1,561 Added 5.84%	28,298 $2.11 Million
Q4 2020 Jan 29, 2021	SELL	$125.56 - $178.74 $87,013 - $123,866	-693 Reduced 2.53%	26,737 $4.56 Million
Q3 2020 Nov 04, 2020	BUY	$127.12 - $172.34 $3.49 Million - $4.73 Million	27,430 New	27,430 $3.87 Million

529

84.1M

2.06M

1.52M

Ticker SRPT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,567,904
Market Cap $11.1B
Description
Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mut...

Get notified when there are updates to the investment portfolio of Royal London Asset Management LTD, based on Form 13F filings with the SEC.

Stay updated on Royal London Asset Management LTD with notifications on news.